FIH and Phase I/II
Early-phase success is predicated on foresight. We specialize in the nuances of Phase I Healthy Volunteer, FIH, and Phase Ib/IIa trials, where the primary objective is generating high-fidelity, investor-grade data.
Our hands-on approach ensures that study endpoints are captured with precision and safety hurdles are managed with the technical rigor required to de-risk your asset for future funding, licensing, or commercial sale.
Later Phase:
Transitioning to larger patient populations (Phase IIb and III) requires a shift from boutique agility to robust operational infrastructure. We provide the therapeutic depth and standardized SOPs necessary to maintain protocol fidelity across multiple sites across Australasia, while preserving the senior-level accountability biotech sponsors require.
Trial Rescue:
A stalled trial is a threat to your burn rate and stakeholder confidence. Southern Star Research is frequently engaged to manage compromised assets through our specialized recovery model.
We have achieved notable success in Trial Rescues inherited from other providers. Our reputation and track record are a testament to our commitment to follow-through, meticulous data collection and operational integrity.
We focus on stabilizing failing timelines, re-engaging investigators and restoring data integrity to bring assets back onto a predictable path to completion.
Don’t wait for the first patient to identify a protocol bottleneck. Speak with our Medical Directors to stress-test your study design for the Asia-Pacific landscape.